NYSE:DGXHealthcare
Quest Diagnostics Expands At Home STI Testing As Valuation Signals Upside Potential
Quest Diagnostics (NYSE:DGX) has partnered with Visby Medical to offer an at-home, FDA authorized PCR test focused on women's sexual health.
The new test targets common STIs and is available directly through Quest's consumer-initiated testing platform.
This move aims to reduce access barriers for STI screening and aligns with broader demand for convenient, at-home diagnostics.
For investors watching NYSE:DGX, this new offering adds another consumer-focused service on top of an existing...